Drug Price Trends for GLYBURIDE

Average Pharmacy Cost for GLYBURIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
GLYBURIDE 1.25 MG TABLET	00093-9477-53	0.07371	EACH	2024-12-18
GLYBURIDE 1.25 MG TABLET	62135-0583-30	0.07371	EACH	2024-12-18
GLYBURIDE 1.25 MG TABLET	72241-0038-05	0.07371	EACH	2024-12-18
GLYBURIDE 1.25 MG TABLET	23155-0056-01	0.07371	EACH	2024-12-18
GLYBURIDE-METFORMIN 5-500 MG	65862-0082-05	0.08679	EACH	2024-12-18

Market Analysis and Price Projections for Glyburide

Introduction to Glyburide

Glyburide, also known as glibenclamide, is a second-generation sulfonylurea used to treat type 2 diabetes mellitus. It works by stimulating the pancreas to produce more insulin, thereby lowering blood glucose levels. Glyburide is typically administered orally and is often recommended in conjunction with diet and exercise for patients who cannot be managed with standard first-line therapy, such as metformin[3][4].

Market Size and Growth

The global glyburide market is anticipated to experience significant growth over the forecast period. Here are some key statistics:

• The global glyburide market size was estimated to be around $1620 million in 2024 and is projected to grow to $2272.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period[4].
• The market is driven by the rising prevalence of type 2 diabetes, an increasing geriatric and obese population, and high R&D investments by pharmaceutical companies to develop more effective diabetes therapies[3][4].

Market Dynamics

Drivers

• Increasing Prevalence of Type 2 Diabetes: The global rise in type 2 diabetes cases is a significant driver for the glyburide market. As the population ages and obesity rates increase, the demand for antidiabetic medications like glyburide is expected to grow[3][4].
• R&D Investments: Pharmaceutical companies are investing heavily in research and development to create more effective and safer treatments for diabetes, which includes the development of fixed-dose combinations and combination drugs with glyburide[3][4].
• Combination Therapies: The presence of fixed-dose combinations and combination drugs with glyburide is expected to boost market growth as these formulations offer better therapeutic outcomes and patient compliance[3].

Restraints

• Side Effects: Glyburide is associated with several side effects, including heartburn, nausea, and angioedema, which can hinder market growth. These adverse effects may lead to a preference for other antidiabetic medications with better safety profiles[3].

Market Segmentation

By Therapeutic Effect

• The glyburide market is segmented based on therapeutic effect, primarily focusing on the treatment of type 2 diabetes mellitus and blood sugar management. Other therapeutic effects may also be considered, but type 2 diabetes remains the primary application[3][4].

By Application

• The market is segmented by application, with a focus on pediatric and geriatric patients. Geriatric patients are a significant segment due to the higher prevalence of type 2 diabetes in this age group[3][4].

Regional Analysis

The glyburide market is analyzed across various regions, including North America, Europe, Asia-Pacific, and other countries. The regional analysis provides insights into market size, revenue, and growth rates in these areas.

• North America: This region is expected to be a significant market due to the high prevalence of type 2 diabetes and well-established healthcare infrastructure[4].
• Asia-Pacific: Countries like China, India, and Japan are expected to drive growth due to their large populations and increasing incidence of diabetes[4].

Price Analysis

The cost of glyburide varies based on the dosage and the pharmacy.

• Micronized 1.5 mg: The cost for 100 tablets can range from $23.76 to $29.76, depending on the pharmacy and any discounts applied[2].
• Micronized 3 mg: The cost for 100 tablets is approximately $28.86 to $29, with lower prices for larger quantities[2].
• Micronized 6 mg: The cost for 100 tablets is around $57.89[2].

Price Projections

The price of glyburide is expected to remain relatively stable, with some fluctuations based on market dynamics and pharmaceutical company strategies.

• Historical and Forecasted Prices: The global glyburide price is analyzed from 2019 to 2030, with forecasts indicating stable prices due to competitive market conditions and generic availability[4].
• Impact of COVID-19: The COVID-19 pandemic has highlighted the importance of agile supply chain management in the pharmaceutical industry, which may influence pricing strategies to ensure consistent supply and affordability[4].

Competitive Landscape

The glyburide market is competitive, with several key players involved.

• Major Manufacturers: Companies such as Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, and others are major stakeholders in the glyburide market. These companies are profiled in terms of their market share, revenue, and competitive positioning[4].

Market Trends

Technological Trends

• Advances in drug delivery systems and the development of more effective combination therapies are expected to influence the market positively[1][4].

Regulatory Trends

• Regulatory changes and healthcare policies, especially those related to drug pricing and accessibility, can impact the market. For instance, any changes in reimbursement policies or pricing regulations can affect the demand and pricing of glyburide[1].

Consumer Behavior Analysis

Consumer behavior plays a crucial role in the glyburide market.

• Patient Compliance: Patients' adherence to treatment regimens and their preference for combination therapies or fixed-dose combinations can influence market trends[1].
• Cost Sensitivity: The cost of glyburide and the availability of patient assistance programs or discounts can significantly affect consumer behavior and market demand[2].

Key Takeaways

• The global glyburide market is expected to grow significantly due to the increasing prevalence of type 2 diabetes and high R&D investments.
• The market is segmented by therapeutic effect and application, with a focus on geriatric patients.
• Prices are expected to remain relatively stable, with some variations based on dosage and pharmacy.
• The competitive landscape is dominated by several major pharmaceutical companies.
• Technological and regulatory trends will continue to shape the market.

FAQs

Q1: What is glyburide used for? Glyburide is used to treat type 2 diabetes mellitus by stimulating the pancreas to produce more insulin, thereby lowering blood glucose levels[3].

Q2: What are the common side effects of glyburide? Common side effects of glyburide include heartburn, nausea, and angioedema[3].

Q3: How much does glyburide cost? The cost of glyburide varies based on the dosage, but for example, a supply of 100 tablets of micronized 3 mg glyburide can cost around $28.86 to $29[2].

Q4: What are the key drivers of the glyburide market? The key drivers include the rising prevalence of type 2 diabetes, an increasing geriatric and obese population, and high R&D investments by pharmaceutical companies[3][4].

Q5: Which regions are expected to drive the growth of the glyburide market? North America, Europe, and the Asia-Pacific region are expected to be significant markets due to their large populations and well-established healthcare infrastructures[4].

Sources

1. Global Glyburide Market Report 2024 Edition - Cognitivemarketresearch.com
2. Glyburide Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
3. Glyburide Market Size and Forecasts (2021 - 2031), Global and Regional Analysis - Theinsightpartners.com
4. Global Glyburide Market Insights, Forecast to 2030 - QYResearch.com
5. Understanding the Cost Dynamics of Antidiabetic Medications - Milliman.com